Health In Tech, Inc.
Stock Watch
Stock Watch will tell you what changes at Health In Tech, Inc..
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 0.3955 $ to 2.00 $ · Last price: 0.3955 $ (As of: November 13, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 11/14/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Software - Application
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Health In Tech, Inc. HIT | 0.0 | – | 291.3 | 53.9 | -24.6 | 71.0 | -74.8 |
| Salesforce.com Inc CRM | 174.5 | 21.8 | 12.6 | 77.3 | 21.8 | 9.6 | -8.6 |
| Uber Technologies Inc UBER | 141.9 | 19.0 | 23.8 | 41.4 | 14.6 | 18.3 | -24.1 |
| Automatic Data Processing Inc ADP | 123.9 | 28.4 | 17.5 | 48.8 | 30.2 | 7.1 | 24.5 |
| ServiceNow Inc NOW | 102.3 | 59.4 | 31.8 | 73.1 | 13.3 | 20.9 | -39.8 |
| Snowflake Inc. SNOW | 99.2 | – | -76.6 | 67.0 | -22.2 | 29.2 | 10.7 |
| Adobe Systems Incorporated ADBE | 95.4 | 13.9 | 9.1 | 89.3 | 35.3 | 10.5 | -27.1 |
| Intuit Inc INTU | 93.9 | 21.8 | 13.0 | 81.0 | 47.0 | 15.6 | -46.7 |
| Cadence Design Systems Inc CDNS | 89.1 | 72.7 | 39.8 | 85.7 | 29.7 | 14.1 | 2.2 |
| Median of companies shown | 99.2 | 21.8 | 17.5 | 73.1 | 21.8 | 15.6 | -24.1 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2022 | 6 | 0 | 0 | 0.00 | 1 | 1 | 29 |
| 2023 | 19 | 3 | 2 | 0.05 | 2 | 6 | 12 |
| 2024 | 19 | 1 | 1 | 0.01 | 2 | 13 | 16 |
| 2025 | 33 | 2 | 1 | 0.02 | 3 | 17 | 23 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q2 | – | – | 5 | 10.20 | 6.80 | 1 | 1 |
| 2024: Q3 | – | – | 5 | -14.90 | 8.40 | 2 | 2 |
| 2024: Q4 | -0.01 | – | 5 | -6.00 | -2.90 | -1 | -1 |
| 2025: Q1 | 0.01 | – | 8 | 56.40 | 6.20 | 1 | 0 |
| 2025: Q2 | 0.01 | – | 9 | 86.20 | 6.80 | 2 | 1 |
| 2025: Q3 | 0.01 | – | 9 | 90.40 | 5.30 | 1 | -1 |
| 2025: Q4 | -0.01 | 0.00 | 8 | 53.10 | -4.00 | 1 | 0 |
| 2026: Q1 | -0.03 | -400.00 | 9 | 9.40 | -18.10 | -3 | -4 |
| 2026: Q2 | -0.04 | -500.00 | 8 | -12.90 | -30.90 | -3 | -3 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.16 | -0.20 – -0.12 | 32 | -900.0% | 2 |
| 12/31/2027 | -0.02 | -0.14 – 0.10 | 54 | 87.5% | 2 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 79.4%
- More than 10% revenue growth is expected for the coming year -62.0%
- Share count grows by less than 3% a year 2.2%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 70.8%
- Gross margin at 40% or higher and without meaningful erosion 62.8%
- Goodwill from acquisitions does not grow faster than revenue 0.0%
- Net debt below twice EBITDA 8 m net cash
- Operating cash flow covers the profits of the last three years 2 m
- Return on capital at 15% or higher, or up versus two years ago 8.5%
- Insiders hold at least 10% or are net buyers 62.0%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
4/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% –
- Exp. sales growth 3Y > 5% 27.4%
- EBIT growth 10Y > 5% –
- Exp. EBIT growth 3Y > 5% 27.4%
- Net debt < 4x EBIT -4.9x
- EBIT positive, 10Y straight –
- Max. EBIT decline < 50% –
- Return on equity > 15% 12.1%
- ROCE > 15% 8.5%
- Expected return > 10% 27.1%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | Hasan Zain Syed | Chief Growth Officer | Sell | 1,667 | 0.55 | 917 |
| Oct 20, 2026 | Shrestha Sanjay K | Chief Executive Officer | Other | 500,000 | 0.00 | – |
| Oct 20, 2026 | Shrestha Sanjay K | Chief Executive Officer | Other | 1,500,000 | 0.00 | – |
| Oct 20, 2026 | Shrestha Sanjay K | Chief Executive Officer | Other | 2,000,000 | 0.00 | – |
| Oct 16, 2026 | Hasan Zain Syed | Chief Growth Officer | Sell | 3,333 | 0.62 | 2,066 |
| Oct 15, 2026 | Johnson Tim Donald | Chief Executive Officer | Other | 119,728 | 0.63 | 75,429 |
| Oct 15, 2026 | Hasan Zain Syed | Chief Growth Officer | Other | 6,756 | 0.63 | 4,256 |
| Oct 15, 2026 | Qian LinLin | Chief Executive Officer | Other | 47,516 | 0.63 | 29,935 |
| Oct 7, 2026 | Hayes Timothy | Director | Other | 26,301 | 0.76 | 19,989 |
| Oct 7, 2026 | Howard William D. | Director | Other | 26,301 | 0.76 | 19,989 |
The company
About the Company
Health In Tech, Inc. ist in den Vereinigten Staaten als Versicherungstechnologie-Plattformunternehmen tätig. Das Unternehmen bietet referenzbasierte Preisgestaltung, Gruppenversicherungs-Captives, Community-Gesundheitspläne und Verbandsgesundheitsprogramme für kleine Unternehmen an; SMR, einen Programmmanager, der auf individuelle selbstfinanzierte Leistungspläne für Unternehmen spezialisiert ist; ICE, einen MGU, der sich auf die Zeichnung und Bereitstellung administrativer Funktionen im Namen von Stop-Loss-Versicherern spezialisiert; sowie das erweiterte Do-it-yourself-Leistungssystem (eDIYBS), eine webbasierte SaaS-Angebotsplattform zur Angebotserstellung für Krankenversicherungen für kleine und mittlere Arbeitgeber. Es bietet zudem Health-Intelligence-Karten (HI) zur Vereinfachung der Verwaltung von Krankenakten und Ansprüchen sowie das HI-Performance-Netzwerk, das eine Reihe von Krankenhauseinrichtungen umfasst und Medicare-basierte Erstattungspreise bereitstellt. Health In Tech, Inc. wurde 2014 gegründet und hat seinen Hauptsitz in Stuart, Florida.
- Employees
- 87
- Headquarters
- Stuart, FL
- Address
- 701 S. Colorado Ave, 34994 Stuart, United States
- Phone
- 888 373 0333
- Website
- healthintech.com
- IPO Date
- 12/23/2024
- ISIN
- US42217D1028
Management
| Name | Title | Birth Year |
|---|---|---|
| Tim Johnson | Founder & Executive Chairman | 1965 |
| Sanjay K. Shrestha | Chief Executive Officer | 1974 |
| Julia Qian | CFO & Director | 1975 |
| Sri Rajagopalan | Chief Technology Officer | 1969 |
| John P. McStravock | General Counsel | 1959 |
| Lori Babcock | Chief of Staff | 1964 |
| Zain Hasan | Chief Growth Officer | 1988 |
| Michael Clarkson | Chief Information Security Officer | 1975 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 11/13/2026 Health In Tech, Inc. (HIT): Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
- 11/13/2026 Health In Tech, Inc. (HIT): Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
- 11/13/2026 Health In Tech, Inc. (HIT): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
- 11/12/2026 Health In Tech, Inc. (HIT): Submission of Matters to a Vote of Security Holders SEC ↗
- 11/06/2026 Health In Tech, Inc. (HIT): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits SEC ↗
- 10/26/2026 Health In Tech, Inc. (HIT): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
- 10/16/2026 Health In Tech, Inc. (HIT): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing SEC ↗
- 09/30/2026 Health In Tech, Inc. (HIT): Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.